MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-07-2024
Silk Road Medical, Inc Long-Term Debt 2011-2026 | SILK
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Silk Road Medical, Inc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.6 M | 74.6 M | 44.8 M | 48.5 M | 44.9 M | 44.2 M | 27.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75.6 M | 27.6 M | 51.5 M |
Quarterly Long-Term Debt Silk Road Medical, Inc
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.1 M | 75.9 M | 75.6 M | 75.4 M | 75.1 M | 74.8 M | 74.6 M | 74.3 M | 74 M | 38.9 M | 44.8 M | 48.7 M | 48.6 M | 48.6 M | 48.5 M | 48.5 M | 48.5 M | 48.5 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 76.1 M | 38.9 M | 56 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 12.24 | 1.7 % | $ 1.65 B |  USA |
 |
Apyx Medical Corporation
APYX
|
34.8 M | $ 3.84 | 4.21 % | $ 158 M | USA |
 |
Alphatec Holdings
ATEC
|
501 M | $ 10.96 | 1.2 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
48.4 M | $ 33.3 | -3.31 % | $ 1.53 B | USA |
 |
Butterfly Network
BFLY
|
20.4 M | $ 4.09 | -0.61 % | $ 866 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 36.54 | -0.58 % | $ 5.44 K | USA |
 |
Boston Scientific Corporation
BSX
|
11.1 B | $ 62.41 | -0.65 % | $ 92.4 B | USA |
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
49.1 M | $ 9.32 | -0.48 % | $ 264 M | USA |
 |
CONMED Corporation
CNMD
|
834 M | $ 34.67 | -0.34 % | $ 1.08 B | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.6 | 2.73 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
835 K | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
2 M | $ 3.43 | 1.18 % | $ 128 M |  France |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
598 M | $ 80.92 | -0.16 % | $ 47.3 B | USA |
 |
FONAR Corporation
FONR
|
155 K | $ 18.59 | - | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Globus Medical
GMED
|
436 K | $ 87.63 | -0.33 % | $ 11.8 B | USA |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
88.2 M | $ 170.68 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.87 | 0.54 % | $ 1.14 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 9.34 | -1.99 % | $ 719 M | USA |
 |
Inogen
INGN
|
14.3 M | $ 6.41 | 3.14 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
98 K | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
2 K | $ 97.04 | 0.84 % | $ 1.23 B | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.19 B | $ 85.1 | -2.01 % | $ 2.96 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.9 | -1.0 % | $ 373 M | USA |
 |
Second Sight Medical Products
EYES
|
17.1 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
1.99 M | $ 6.01 | -0.91 % | $ 71.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
37 M | $ 1.39 | 4.14 % | $ 56.6 M | USA |
 |
Medtronic PLC
MDT
|
25.6 B | $ 86.29 | -0.39 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
16.5 M | $ 3.86 | -1.53 % | $ 570 M | USA |